LOC646836: A Potential Drug Target (G646836)
LOC646836: A Potential Drug Target
LOC646836 is a protein that is located in the endoplasmic reticulum (ER) and is involved in the regulation of protein stability and localization. It has been identified as a potential drug target and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The ER is a membrane-wrapped structure that is an important place for intracellular protein synthesis and modification. Endoplasmic reticulum (ER) is a membrane-bound structure that is involved in the regulation of protein stability and localization. It has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
LOC646836 is a protein that is located in the ER and is involved in the regulation of protein stability and localization. It has been shown to play a role in the regulation of a variety of protein levels, including the level of the protein known as Bcl- 2. Bcl-2 is a protein that is known to play a role in the regulation of cell growth and differentiation, and is often involved in the development of cancer.
LOC646836 has also been shown to play a role in the regulation of the level of the protein known as p53. P53 is a protein that is known to play a role in the regulation of cell growth and differentiation, and is often involved in the development of cancer.
LOC646836 has been shown to play a role in the regulation of the level of the protein known as NF-kappa-B. NF-kappa-B is a protein that is involved in the regulation of inflammation and immune responses, and is often involved in the development of autoimmune disorders.
LOC646836 has also been shown to play a role in the regulation of the level of the protein known as TGF-β. TGF-β is a protein that is involved in the regulation of cell growth and differentiation, and is often involved in the development of cancer.
LOC646836 has been shown to play a role in the regulation of the level of the protein known as SMAD. SMAD is a protein that is involved in the regulation of gene expression, and is often involved in the development of cancer.
LOC646836 has also been shown to play a role in the regulation of the level of the protein known as p16INK4a. p16INK4a is a protein that is involved in the regulation of cell growth and differentiation, and is often involved in the development of cancer.
LOC646836 has been shown to play a role in the regulation of the level of the protein known as tamoxifen. Tamoxifen is a drug that is often used to treat breast cancer, and is thought to work by inhibiting the activity of estrogen receptors.
LOC646836 has also been shown to play a role in the regulation of the level of the protein known as progesterone. Progesterone is a hormone that is often used to treat pregnancy, and is thought to work by simulating the activity of estrogen receptors.
LOC646836 has been shown to play a role in the regulation of the level of the protein known as GABA. GABA is a neurotransmitter that is often involved in the regulation of anxiety and depression, and is thought to work by modulating the activity of ion channels in Neurons.
LOC646836 has also been shown to play a role in the regulation of the level of the protein known as GLUT4. GLUT4 is a protein that is involved in the regulation of glucose metabolism, and is often involved in the development of diabetes.
LOC646836 has been shown to play a role in the regulation of the level of the protein known as FFA. FFA is a protein that is involved in the regulation of fatty acid metabolism, and is often involved in the development of obesity.
LOC646836 has been shown to play a role in the regulation of the level of the protein known as
Protein Name: Uncharacterized LOC646836
The "LOC646836 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC646836 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2 | LONRF1 | LONRF2 | LONRF3 | LORICRIN | LOX | LOXHD1 | LOXL1 | LOXL1-AS1 | LOXL2 | LOXL3 | LOXL4 | LPA | LPAL2 | LPAR1 | LPAR2 | LPAR3 | LPAR4 | LPAR5 | LPAR6 | LPCAT1 | LPCAT2 | LPCAT3 | LPCAT4 | LPGAT1 | LPIN1 | LPIN2 | LPIN3 | LPL | LPO | LPP
